Skip to Main Content

Paper Details

Metabolic dysfunction-related liver disease as a risk factor for cancer.
BMJ Open Gastroenterol
11
2022
Diabetes, FIB-4, FLI, Fatty Liver, MDLD, Metabolic dysfunction, Metabolic dysfunction-related liver disease, NAFLD, NASH, PNPLA3 rs738409, Participants, SHARE, T2DM, alanine, alanine transaminase, alcohol abuse, cancer, diabetes, diabetics, liver disease, liver dysfunction, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obesity, patients, type 2 diabetes, type 2 diabetes mellitus
Author NameAffiliation
Moneeza K SiddiquiUniversity of Dundee
Alex S F DoneyUniversity of Dundee
Alex S F DoneyUniversity of Dundee
  • 1 - 3

Datasets

Release 1.2